Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

Trends in the purchase of test equipment indicate that production line electrical safety is moving away from the traditional ground continuity test in favor of
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Lombard Medical launches post-market Aorfix study

April 17, 2015 by Mark Hollmer

Lombard Medical Technologies launches a post-market study of its Aorfix stent graft for abdominal aortic aneurysms.

Lombard Medical launches post-market Aorfix study

MassDevice.com +3 | The top 3 medtech stories for April 17, 2015

April 17, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Glaucoma treatment: InFocus meets enrollment goal on MicroShunt clinical trial

April 17, 2015 by Val Kennedy

InnFocus reaches its goal of enrolling 75 patients in a Phase I clinical study for its MicroShunt glaucoma eye-drainage implant.

thumb_innfocus.png

InnFocus has reached its goal of enrolling 75 patients in a Phase I clinical study for its MicroShunt glaucoma eye-drainage implant.

The device is used to help reduce pressure within the eye in patients with glaucoma. The product is intended to be an alternative to traditional glaucoma surgery.

FDA bars Stanmore Implants from U.S. market

April 17, 2015 by Mark Hollmer

The FDA bars imports from the U.K.'s Stanmore Implants until it deals with problems flagged in an FDA warning letter alleging numerous quality manufacturing violations.

FDA bars Stanmore Implants from U.S. market

The FDA slapped Stanmore Implants with an import ban until the British orthopedic implant maker deals with problems flagged in a warning letter from the federal safety watchdog.

FDA clears Conventus PH shoulder cage

April 17, 2015 by Mark Hollmer

The FDA grants 510(k) clearance to the Conventus PH shoulder cage for treating shoulder fractures.

FDA clears Conventus PH shoulder cage

Conventus Orthopaedics, with an FDA clearance in hand, plans a gradual rollout of a new device designed to help repair shoulder fractures in a less invasive way.

Report: Actavis to lay off 577 at Allergan

April 17, 2015 by Brad Perriello

Actavis, the new owner of Allergan, reportedly plans to lay off 577 workers in Irvine, Calif.

Report: Actavis to lay off 577 at Allergan

Medtech investment in Minnesota falls back to earth

April 17, 2015 by Scott Wooldridge

First-quarter investment in Minnesota's thriving medtech cluster falls back to earth after exploding off the charts last year.

Medtech investment in Minnesota falls back to earth

After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley.